Cover Image
市場調查報告書

Nerviano Medical Sciences - 產品平台分析

Nerviano Medical Sciences - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 204923
出版日期 內容資訊 英文 52 Pages
訂單完成後即時交付
價格
Back to Top
Nerviano Medical Sciences - 產品平台分析 Nerviano Medical Sciences - Product Pipeline Review - 2014
出版日期: 2014年07月31日 內容資訊: 英文 52 Pages
簡介

Nerviano Medical Sciences是研究、開發抗癌劑藥物的製藥公司。該公司同時也提供臨床研究和法規活動,研究管理,醫藥品的安全管理,臨床資料管理等服務。

本報告提供Nerviano Medical Sciences 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Nerviano Medical Sciences 基本資料

Nerviano Medical Sciences 概要

  • 主要資訊
  • 企業資料

Nerviano Medical Sciences :R&D概要

  • 主要的治療範圍

Nerviano Medical Sciences :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

Nerviano Medical Sciences :開發中產品概況

Nerviano Medical Sciences

  • 臨床實驗階段的開發中產品
    • 第二階段
  • 某產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Nerviano Medical Sciences :藥物簡介

  • danusertib
  • milciclib
  • nemorubicin
  • NMS-E628
  • NMS-1116354
  • NMS-1286937
  • NMS-616
  • NMS-P118
  • NMS-P153
  • NMS-P285
  • NMS-P506
  • NMS-P626
  • NMS-P648
  • NMS-P715
  • NMS-P914
  • NMS-P948
  • NMSE-973
  • PHA-793887
  • Small Molecule to Inhibit RET for Oncology
  • NMS-873
  • Small Molecule to Inhibit Pim Kinase for Oncology

Nerviano Medical Sciences :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Nerviano Medical Sciences :最近的開發平台趨勢

Nerviano Medical Sciences :暫停中的計劃

Nerviano Medical Sciences :總公司和子公司的所地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC05260CDB

Summary

Global Markets Direct's, 'Nerviano Medical Sciences - Product Pipeline Review - 2014', provides an overview of the Nerviano Medical Sciences 's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Nerviano Medical Sciences 's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Nerviano Medical Sciences including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Nerviano Medical Sciences 's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Nerviano Medical Sciences 's pipeline products

Reasons to buy

  • Evaluate Nerviano Medical Sciences 's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Nerviano Medical Sciences in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Nerviano Medical Sciences 's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Nerviano Medical Sciences and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Nerviano Medical Sciences
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Nerviano Medical Sciences and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Nerviano Medical Sciences Snapshot
    • Nerviano Medical Sciences Overview
    • Key Information
    • Key Facts
  • Nerviano Medical Sciences - Research and Development Overview
    • Key Therapeutic Areas
  • Nerviano Medical Sciences - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Nerviano Medical Sciences - Pipeline Products Glance
    • Nerviano Medical Sciences - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Nerviano Medical Sciences - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Nerviano Medical Sciences - Drug Profiles
    • danusertib
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • milciclib
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • nemorubicin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-E628
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-1116354
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-1286937
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-616
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-P118
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-P153
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-P285
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-P506
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-P626
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-P648
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-P715
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-P914
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-P948
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMSE-973
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PHA-793887
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit RET for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NMS-873
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Pim Kinase for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Nerviano Medical Sciences - Pipeline Analysis
    • Nerviano Medical Sciences - Pipeline Products by Target
    • Nerviano Medical Sciences - Pipeline Products by Route of Administration
    • Nerviano Medical Sciences - Pipeline Products by Molecule Type
    • Nerviano Medical Sciences - Pipeline Products by Mechanism of Action
  • Nerviano Medical Sciences - Recent Pipeline Updates
  • Nerviano Medical Sciences - Dormant Projects
  • Nerviano Medical Sciences - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Nerviano Medical Sciences, Key Information
  • Nerviano Medical Sciences, Key Facts
  • Nerviano Medical Sciences - Pipeline by Indication, 2014
  • Nerviano Medical Sciences - Pipeline by Stage of Development, 2014
  • Nerviano Medical Sciences - Monotherapy Products in Pipeline, 2014
  • Nerviano Medical Sciences - Out-Licensed Products in Pipeline, 2014
  • Nerviano Medical Sciences - Out-Licensed Products/ Combination Treatment Modalities, 2014
  • Nerviano Medical Sciences - Phase II, 2014
  • Nerviano Medical Sciences - Phase I, 2014
  • Nerviano Medical Sciences - Preclinical, 2014
  • Nerviano Medical Sciences - Discovery, 2014
  • Nerviano Medical Sciences - Pipeline by Target, 2014
  • Nerviano Medical Sciences - Pipeline by Route of Administration, 2014
  • Nerviano Medical Sciences - Pipeline by Molecule Type, 2014
  • Nerviano Medical Sciences - Pipeline Products by Mechanism of Action, 2014
  • Nerviano Medical Sciences - Recent Pipeline Updates, 2014
  • Nerviano Medical Sciences - Dormant Developmental Projects,2014

List of Figures

  • Nerviano Medical Sciences - Pipeline by Top 10 Indication, 2014
  • Nerviano Medical Sciences - Pipeline by Stage of Development, 2014
  • Nerviano Medical Sciences - Monotherapy Products in Pipeline, 2014
  • Nerviano Medical Sciences - Out-Licensed Products in Pipeline, 2014
  • Nerviano Medical Sciences - Pipeline by Top 10 Target, 2014
  • Nerviano Medical Sciences - Pipeline by Top 10 Route of Administration, 2014
  • Nerviano Medical Sciences - Pipeline by Top 10 Molecule Type, 2014
  • Nerviano Medical Sciences - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top